Results 291 to 300 of about 5,575,329 (338)

Immune-related adverse events occurring rapidly after a single dose of immune checkpoint blockade. [PDF]

J Immunother Cancer
Guitton R, Laparra A, Chanson N, Champiat S, Danlos FX, Michot JM, Messayke S, Marabelle A, Lambotte O.   +8 more
europepmc   +1 more source

Immune Checkpoint Inhibitors and Cardiovascular Adverse Events. [PDF]

ESC Heart Fail
De Perna ML, Rigamonti E, Zannoni R, Espeli V, Moschovitis G.   +4 more
europepmc   +1 more source

Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors. [PDF]

Acta Derm Venereol
Schwarz CW, Näslund-Koch C, Zachariae C, Seidelin JB, Nielsen SD, Ostrowski SR, Astvad KMT, Brock I, Iversen L, Rasmussen MK, Loft N, Skov L.   +11 more
europepmc   +1 more source

Exposure-safety Markov modeling of ocular adverse events in patient populations treated with tisotumab vedotin. [PDF]

J Pharmacokinet Pharmacodyn
Feng S, Gunawan R, Passey C, Voellinger J, Polhamus D, Gerritsen A, O'Day C, Carret AS, Soumaoro I, Gupta M, Hanley WD.   +10 more
europepmc   +1 more source

Comedications Associated with Immune-Related Adverse Events from Immune-Checkpoint Inhibitors. [PDF]

Clin Pharmacol Ther
Laurent L, Abbar B, Bihan K, Dumas E, Jochum F, Lebrun-Vignes B, Spano JP, Salem JE, Hamy AS, Reyal F, Gougis P.   +10 more
europepmc   +1 more source